Evidence map›Paper›PMID 30759228›Full record

ArticleJournal of the Pediatric Infectious Diseases Society2020

Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016.

Huong Q McLean, Jennifer P King, Pamela Talley, Brendan Flannery, Sarah Spencer, Min Z Levine, Thomas C Friedrich, Edward A Belongia

Open access · hybridAbstract read
In one paragraph

Article in Journal of the Pediatric Infectious Diseases Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects Persist.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Huong Q McLeanCenter for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Wisconsin.
Jennifer P KingCenter for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Wisconsin.
Pamela TalleyEpidemic Intelligence Service, Division of Scientific Education and Professional Development.
Brendan FlanneryInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Sarah SpencerInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Min Z LevineInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Thomas C FriedrichDepartment of Pathobiological Sciences, University of Wisconsin School of Veterinary Medicine and Wisconsin National Primate Research Center, Madison.
Edward A BelongiaCenter for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Wisconsin.
Centers for Disease Control and Prevention · USMarshfield Clinic · USEpidemic Intelligence Service · USUniversity of Wisconsin–Madison · US

Funding

Annual Estimates of Influenza Vaccine Effectiveness and Evaluation of Immune Response in a Wisconsin PopulationU01IP001038 · IP · MARSHFIELD CLINIC RESEARCH FOUNDATION · PI BELONGIA, EDWARD · 2016 to 2020
$8.0M
ACL HHS U01IP001038NCIRD CDC HHS U01 IP001038
6 · The paper itself

Abstract

backgroundThe effects of repeated influenza vaccination in children are not well understood. In this study, we evaluated previous vaccination effects on antibody response after vaccination with trivalent inactivated influenza vaccine (IIV) or quadrivalent live-attenuated influenza vaccine (LAIV) among school-aged children (5-17 years) across 3 seasons.

methodsChildren were enrolled in the fall of 2013, 2014, and 2015. The participants received IIV or LAIV according to parent preference (2013-2014) or our randomization scheme (2014-2015). All study children received IIV in 2015-2016. Hemagglutination-inhibition assays measured antibody response to egg-grown vaccine strains from prevaccination and postvaccination serum samples. Geometric mean titers (GMTs) and increases in GMTs from before to after vaccination (geometric mean fold rise [GMFR]) were estimated from repeated-measures linear mixed models.

resultsWe enrolled 161 children in 2013-2014, 128 in 2014-2015, and 126 in 2015-2016. Among the IIV recipients, responses to the influenza A(H1N1)pdm09 and B vaccine strains were lowest among children who had received a previous-season IIV. The GMFRs for strains A(H1N1)pdm09 and B were 1.5 to 2.3 for previous-season IIV and 4.3 to 12.9 for previous-season LAIV or no previous vaccine. GMFRs were lower for strain A(H3N2), and differences according to previous-season vaccination history were smaller and not significant in most seasons. Most children had a post-IIV vaccination titer of ≥40 for vaccine strains in all seasons, regardless of previous-season vaccination history. Little to no increase in antibody levels was observed after vaccination with LAIV.

conclusionsSerologic response to vaccination was greatest for IIV, but previous-season vaccination modified IIV response to A(H1N1)pdm09 and B. Influenza A(H3N2) responses were low in all groups, and LAIV generated minimal serologic response against all strains.

Indexed as

AdolescentAntibodies, ViralChildChild, PreschoolFemaleHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza B virusInfluenza, HumanInfluenza VaccinesMaleSeasonsVaccinationAntibodies, ViralInfluenza Vaccineschildrenimmune responseinfluenzainfluenza vaccination

Identifiers

PMID30759228
PMCPMC7192403
OpenAlexW2914265886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.